• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS ELECSYS RUBELLA IGG; ENZYME LINKED IMMUNOABSORBENT ASSAY, RUBELLA

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS ELECSYS RUBELLA IGG; ENZYME LINKED IMMUNOABSORBENT ASSAY, RUBELLA Back to Search Results
Catalog Number 07027770190
Medical Device Problem Code Low Test Results (2458)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 09/14/2024
Type of Reportable Event Malfunction
Event or Problem Description
The initial reporter stated they received discrepant results for one patient sample tested with elecsys rubella igg on a cobas e 801 module.The sample initially resulted in a rubella igg value of 4.94 ui/ml (negative) when tested using the roche method.The sample was repeated on a liaison xl analyzer on (b)(6) 2025, resulting in a rubella igg value of 13.90 ui/ml (positive).
 
Additional Manufacturer Narrative
The serial number of the e 801 analyzer is (b)(6).The patient sample was requested for investigation and it was received for investigation.The investigation is ongoing.
 
Additional Manufacturer Narrative
Investigations of the patient sample were able to reproduce the results obtained by the customer.During investigations, the sample was tested using the mikrogen recomblot rubella igg method and the result was clearly positive.This indicates the presence of anti-rubella igg antibodies.The patient sample very likely contains anti-rubella igg antibodies and the elecsys rubella igg non-reactive result is incorrect.False non-reactive results can occur with the elecsys rubella igg assay.The product labeling states, "for diagnostic purposes, the results should always be assessed in conjunction with the patient¿s medical history, clinical examination and other findings." the investigation did not identify a product issue.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELECSYS RUBELLA IGG
Common Device Name
ENZYME LINKED IMMUNOABSORBENT ASSAY, RUBELLA
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhofer strasse 116
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
amy nelson
9115 hague road
indianapolis, IN 46250
MDR Report Key21432204
Report Number1823260-2025-00507
Device Sequence Number4683663
Product Code LFX
UDI-Device Identifier04015630940240
UDI-Public04015630940240
Combination Product (Y/N)N
Initial Reporter CountryFR
PMA/510(K) Number
K072617
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Foreign,Health Professional
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 03/11/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date03/31/2025
Device Catalogue Number07027770190
Device Lot Number786976
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 02/03/2025
Supplement Date Received by Manufacturer03/10/2025
Initial Report FDA Received Date02/21/2025
Supplement Report FDA Received Date03/11/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Is the Device Labeled for Single Use? (Y/N) No
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Patient Age25 YR
Patient SexFemale
-
-